[HTML][HTML] 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes—2023
NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2023 - ncbi.nlm.nih.gov
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study …
MJ Davies, VR Aroda, BS Collins, RA Gabbay… - Diabetes …, 2022 - Am Diabetes Assoc
The American Diabetes Association and the European Association for the Study of Diabetes
convened a panel to update the previous consensus statements on the management of …
convened a panel to update the previous consensus statements on the management of …
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021
American Diabetes Association - Diabetes care, 2021 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the …
the ADA's current clinical practice recommendations and is intended to provide the …
[HTML][HTML] Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for …
Abstract The American Diabetes Association and the European Association for the Study of
Diabetes convened a panel to update the previous consensus statements on the …
Diabetes convened a panel to update the previous consensus statements on the …
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional … - Diabetes …, 2022 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the …
the ADA's current clinical practice recommendations and is intended to provide the …
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024.
NA ElSayed, G Aleppo, RR Bannuru… - Diabetes …, 2024 - search.ebscohost.com
Abstract The American Diabetes Association (ADA)" Standards of Care in Diabetes"
includes the ADA's current clinical practice recommendations and is intended to provide the …
includes the ADA's current clinical practice recommendations and is intended to provide the …
[HTML][HTML] Recent updates to clinical practice guidelines for diabetes mellitus
J Yu, SH Lee, MK Kim - Endocrinology and Metabolism, 2022 - synapse.koreamed.org
Guidelines for the management of patients with diabetes have become an important part of
clinical practice that improve the quality of care and help establish evidence-based medicine …
clinical practice that improve the quality of care and help establish evidence-based medicine …
Reconsidering the role of glycaemic control in cardiovascular disease risk in type 2 diabetes: a 21st century assessment
VR Aroda, RH Eckel - Diabetes, Obesity and Metabolism, 2022 - Wiley Online Library
It is well known that the multiple factors contributing to the pathogenesis of type 2 diabetes
(T2D) confer an increased risk of developing cardiovascular disease (CVD). Although the …
(T2D) confer an increased risk of developing cardiovascular disease (CVD). Although the …
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024
Diabetes Care, 2024 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
[HTML][HTML] Metabolic control and adherence to therapy in type 2 diabetes mellitus patients using IDegLira in a real-world setting
C Melzer-Cohen, G Chodick, S Naftelberg… - Diabetes Therapy, 2020 - Springer
Abstract Introduction Insulin degludec/liraglutide (IDegLira) is a fixed-ratio combination
(FRC) of basal insulin and glucagon-like protein-1 receptor agonist (GLP-1 RA) that has …
(FRC) of basal insulin and glucagon-like protein-1 receptor agonist (GLP-1 RA) that has …